The disclosure herein relates generally to methods for treat ing heart conditions using Vagal
stimulation, and further to systems and devices for performing Such treatment. Such …

An implantable device for evaluating autonomic cardiovascular drive in a patient suffering
from chronic cardiac dysfunction is provided. A stimulation therapy lead includes helical …

5,928,272 A 7, 1999 Adkins et al. 5,978,709 A 11/1999 Begemann et al. 6,006,134 A 12,
1999 Hill et al. 6,266,564 B1 7, 2001 Hill et al. ently activate the hearts intrinsic nervous …

(57) ABSTRACT A method for managing hypertension through renal nerve denervation and
vagus nerve stimulation is provided. Renal nerves are disrupted to inhibit a sympathetic …

An implantable neurostimulator-implemented method for managing tachyarrhythmias upon
a patient's awakening from sleep through vagus nerve stimulation is provided. An …

Multi-modal stimulation therapy may be utilized in which two or more stimulation therapies
having different stimulation parameters may be delivered to a single patient. This can …

Systems and methods are provided for delivering neurostimu lation therapies to patients for
treating chronic heart failure. A neural fulcrum Zone is identified and ongoing neurostimula …

6,006,134. A 12/1999 Hill et al. 7.627, 384 B2 12/2009 Ayal et al. 6,266,564 B1 7/2001 Hill
et al. 7,628,750 B2 12/2009 Cohen et al. 6,354,991 B1 3/2002 Gross et al. 7,630,760 B2 …

An implantable device (11) for evaluating autonomic cardiovascular drive in a patient (10)
suffering from chronic cardiac dysfunction is provided. A stimulation therapy lead (13) …

The disclosure herein relates generally to methods for treating heart conditions using vagal
stimulation, and further to systems and devices for performing such treatment. Such methods …